Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers L Jamali, R Tofigh, S Tutunchi, G Panahi, F Borhani, S Akhavan, ... Journal of cellular physiology 233 (11), 8538-8550, 2018 | 154 | 2018 |
Carcinogenic and non-carcinogenic health risks of metal (oid) s in tap water from Ilam city, Iran Y Fakhri, N Saha, S Ghanbari, M Rasouli, A Miri, M Avazpour, ... Food and chemical toxicology 118, 204-211, 2018 | 109 | 2018 |
Acute myeloid leukemias with UBTF tandem duplications are sensitive to Menin inhibitors JM Barajas, M Rasouli, M Umeda, RL Hiltenbrand, S Abdelhamed, ... Blood Journal, blood. 2023021359, 2023 | 32 | 2023 |
The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML M Rasouli, H Blair, S Troester, K Szoltysek, R Cameron, M Ashtiani, ... HemaSphere 7 (8), 2023 | 24 | 2023 |
SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation Z Jevtic, V Matafora, F Casagrande, F Santoro, S Minucci, M Garre, ... Journal of Experimental & Clinical Cancer Research 41 (1), 1-15, 2022 | 24 | 2022 |
A robust post-insertion method for the preparation of targeted siRNA LNPs LE Swart, CA Koekman, CW Seinen, H Issa, M Rasouli, RM Schiffelers, ... International Journal of Pharmaceutics 620, 121741, 2022 | 22 | 2022 |
Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia H Issa, LE Swart, M Rasouli, M Ashtiani, S Nakjang, N Jyotsana, ... Leukemia 37 (4), 820-834, 2023 | 18 | 2023 |
Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression KL Juul-Dam, NN Shukla, TM Cooper, B Cuglievan, O Heidenreich, ... European Journal of Medical Genetics, 104869, 2023 | 11 | 2023 |
NUP98 oncofusions in myeloid malignancies: An update on molecular mechanisms and therapeutic opportunities M Rasouli, S Troester, F Grebien, BF Goemans, CM Zwaan, ... HemaSphere 8 (9), e70013, 2024 | 5 | 2024 |
Assessing expression of TGF-Β2 and PCDH9 genes in breast cancer patients SH Bidoki, A Bayatani, M Sarlak, M Rasouli, P Mostafaie, M Saghafi, ... Age 7, 20, 2018 | 5 | 2018 |
Menin Inhibition In Hox/Meis1 Dysregulated Amls M Rasouli, R Mohnani, M Ashtiani, A Krippner-Heidenreich, CM Zwaan, ... Klinische Pädiatrie 235 (03), 199-199, 2023 | | 2023 |
New Treatment Opportunity for Acute Myeloid Leukemias Harbouring a UBTF Tandem Duplication R Mohnani | | 2023 |
Inhibition of the Menin-MLL1 Interaction in MLL-Rearranged Primary Mixed-Phenotype Acute Leukemia Samples Promotes Leukemic Differentiation K Szoltysek, RL Cameron, A Krippner-Heidenreich, M Rasouli, ... Blood 140 (Supplement 1), 9191-9191, 2022 | | 2022 |
P314: THERAPEUTICALLY TARGETING THE UNIQUE BARCODE OF MLL/AF4 R Cameron, L Swart, M Rasouli, O Heidenreich HemaSphere 6, 215-216, 2022 | | 2022 |
Targeting the unique barcode of MLL/AF4 R Cameron, L Swart, M Rasouli, O Heidenreich Klinische Pädiatrie 234 (03), 181-181, 2022 | | 2022 |